ATE533061T1 - Verfahren zur diagnose bakterieller infektionen - Google Patents

Verfahren zur diagnose bakterieller infektionen

Info

Publication number
ATE533061T1
ATE533061T1 AT10188288T AT10188288T ATE533061T1 AT E533061 T1 ATE533061 T1 AT E533061T1 AT 10188288 T AT10188288 T AT 10188288T AT 10188288 T AT10188288 T AT 10188288T AT E533061 T1 ATE533061 T1 AT E533061T1
Authority
AT
Austria
Prior art keywords
patient
bacterial infections
diagnosing bacterial
risk
diagnosing
Prior art date
Application number
AT10188288T
Other languages
English (en)
Inventor
Joachim Struck
Andreas Bergmann
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39745280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533061(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07015271A external-priority patent/EP2020603A1/de
Priority claimed from EP08152651A external-priority patent/EP2101178A1/de
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of ATE533061T1 publication Critical patent/ATE533061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT10188288T 2007-08-03 2008-08-01 Verfahren zur diagnose bakterieller infektionen ATE533061T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07015271A EP2020603A1 (de) 2007-08-03 2007-08-03 Verfahren zur Einteilung von Risikoklassen bei stabiler Erkrankung der Koronaraterien
EP08152651A EP2101178A1 (de) 2008-03-12 2008-03-12 Verwendung von Procalcitonin zur Prognose folgender akuter Koronarsyndromen

Publications (1)

Publication Number Publication Date
ATE533061T1 true ATE533061T1 (de) 2011-11-15

Family

ID=39745280

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08786791T ATE514091T1 (de) 2007-08-03 2008-08-01 Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit
AT10188288T ATE533061T1 (de) 2007-08-03 2008-08-01 Verfahren zur diagnose bakterieller infektionen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08786791T ATE514091T1 (de) 2007-08-03 2008-08-01 Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit

Country Status (8)

Country Link
US (3) US20110136161A1 (de)
EP (4) EP2174143B1 (de)
JP (2) JP5059943B2 (de)
CN (3) CN110346577A (de)
AT (2) ATE514091T1 (de)
DE (1) DE602008021800C5 (de)
ES (3) ES2401703T3 (de)
WO (1) WO2009019230A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2174143B1 (de) 2007-08-03 2011-06-22 B.R.A.H.M.S GmbH Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit
CN105334330A (zh) * 2009-04-14 2016-02-17 B.R.A.H.M.S有限公司 通过测定降钙素原水平对在原发性非感染性疾病患者中的抗生素治疗进行风险评估
WO2010139475A1 (en) * 2009-06-05 2010-12-09 B.R.A.H.M.S Gmbh Detection of bacterial infections in subjects suffering from dyspnea
WO2011023813A1 (en) 2009-08-28 2011-03-03 Brahms Gmbh Procalcitonin for the prognosis of adverse events
ES2601104T3 (es) 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio
BR112012022509A2 (pt) * 2010-03-08 2017-09-26 Brahms Gmbh procalcitonina para o diagnóstico de infecções bacterianas e orientação de tratamento antibiótico em pacientes com queixas não específicas.
ITRM20100121A1 (it) * 2010-03-18 2011-09-19 Univ Pisa Marcatori molecolari per infezioni delle vie urinarie.
US20140051183A1 (en) * 2010-06-18 2014-02-20 B.R.A.H.M.S Gmbh Biomarkers for the prediction of incident cancer
US20130024205A1 (en) * 2011-07-18 2013-01-24 International Business Machines Corporation Dynamically updating electronic medical records and leveraging a person's path in a facility to mitgate risks
CA2863819C (en) 2012-02-09 2021-11-23 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
JP5945063B2 (ja) * 2012-04-12 2016-07-05 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 慢性心不全が疑われる患者における有害事象の予後
HK1208624A1 (en) 2012-05-18 2016-03-11 Critical Care Diagnostics, Inc. Methods for treating or predicting risk of a ventricular tachyarrhythmia event
SG10201704311VA (en) * 2012-08-16 2017-07-28 Critical Care Diagnostics Inc Methods for predicting risk of developing hypertension
IN2015DN04062A (de) 2012-11-15 2015-10-09 Ortho Clinical Diagnostics Inc
US10303846B2 (en) 2014-08-14 2019-05-28 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
US20170269081A1 (en) 2014-12-11 2017-09-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
JPWO2016199180A1 (ja) * 2015-06-09 2018-04-12 国立大学法人大阪大学 生物学的製剤による関節リウマチの治療効果の予測判定方法
WO2017149548A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
CN108699609A (zh) 2016-03-03 2018-10-23 米密德诊断学有限公司 分析rna用于诊断感染类型
CN106093416B (zh) * 2016-05-18 2018-10-12 北京北方生物技术研究所有限公司 一种一步法检测降钙素原的试剂盒及其制备方法
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
US11353456B2 (en) 2016-09-29 2022-06-07 Memed Diagnostics Ltd. Methods of risk assessment and disease classification for appendicitis
EP3519833B1 (de) 2016-09-29 2024-08-14 MeMed Diagnostics Ltd. Verfahren zur prognose und behandlung
EP4027145A1 (de) * 2017-09-13 2022-07-13 B.R.A.H.M.S GmbH Pro-adm zur therapieüberwachung von intensivpatienten
JP7444776B2 (ja) * 2017-12-20 2024-03-06 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
CN116685852A (zh) * 2020-12-02 2023-09-01 贝克曼库尔特有限公司 使用参数检测医疗状况、严重性、风险和敏度
CN117280218A (zh) 2021-04-30 2023-12-22 豪夫迈·罗氏有限公司 用于脓毒症的早期检测的strem1标志物组
WO2022229442A2 (en) 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Presepsin marker panels for early detection of sepsis
EP4330679A2 (de) 2021-04-30 2024-03-06 Roche Diagnostics GmbH Esm1-markertafeln zur frühen erkennung von sepsis
WO2022229415A2 (en) 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Gdf15 marker panels for early detection of sepsis
EP4330688A2 (de) 2021-04-30 2024-03-06 Roche Diagnostics GmbH Pct-markerpanels zur früherkennung von sepsis
EP4330681A2 (de) 2021-04-30 2024-03-06 Roche Diagnostics GmbH Igfbp7-markertafeln zur frühen erkennung von sepsis
JP2024516677A (ja) 2021-04-30 2024-04-16 エフ． ホフマン－ラ ロシュ アーゲー 敗血症の早期検出用のｎｇａｌマーカーパネル
US20240230675A1 (en) 2021-04-30 2024-07-11 Roche Diagnostics Operations, Inc. Sflt1 marker panels for early detection of sepsis
CN117242350A (zh) 2021-04-30 2023-12-15 豪夫迈·罗氏有限公司 用于脓毒症的早期检测的il6标志物组
US20250035629A1 (en) 2021-09-29 2025-01-30 Roche Diagnostics Operations, Inc. Mr-proadm marker panels for early detection of sepsis
EP4483186A1 (de) 2022-02-21 2025-01-01 F. Hoffmann-La Roche AG Dll1-markertafeln für den frühen nachweis von sepsis
EP4357778A1 (de) 2022-10-20 2024-04-24 Heraeus Medical GmbH Behandlung von mikrobiellen infektionen mit diagnose durch biomarker d-lactat
CN119306832B (zh) * 2023-07-11 2025-08-08 东莞市朋志生物科技有限公司 抗降钙素原抗体、检测降钙素原的试剂和试剂盒

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227454C1 (de) * 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
US6147688A (en) 1993-06-28 2000-11-14 Athena Design Systems, Inc. Method and apparatus for defining and selectively repeating unit image cells
US5795725A (en) 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
US6156521A (en) 1997-12-19 2000-12-05 Biosite Diagnostics, Inc. Methods for the recovery and measurement of troponin complexes
US5993811A (en) * 1997-02-03 1999-11-30 Biology Associates, Llc Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
DE19903336C2 (de) 1999-01-28 2000-12-14 Brahms Diagnostica Gmbh Gebrauchsfertige Kalibratoren für die Bestimmung von Procalcitonin
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
JP3806694B2 (ja) * 2001-05-04 2006-08-09 バイオサイト インコーポレイテッド 急性冠状動脈症候群の診断マーカーおよびその使用方法
EP1587955A4 (de) 2002-12-24 2007-03-14 Biosite Inc Differenzialdiagnose-marker und verfahren zu ihrer verwendung
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
WO2004094460A2 (en) 2003-04-17 2004-11-04 Ciphergen Biosystems, Inc. Polypeptides related to natriuretic peptides and methods of their identification and use
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE112004001863T5 (de) * 2003-10-03 2006-09-07 Scantibodies Laboratory, Inc., Santee Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität
CA2485722A1 (en) 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor
ATE312351T1 (de) 2004-02-13 2005-12-15 Brahms Ag Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
US20060024744A1 (en) 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004041659A1 (de) 2004-08-27 2006-03-02 Institut Virion/Serion Gmbh Testvorrichtung für die in vitro Diagnostik von Multianalyt-Tests und deren Verwendung
US20070092911A1 (en) 2005-10-03 2007-04-26 Buechler Kenneth F Methods and compositions for diagnosis and /or prognosis in systemic inflammatory response syndromes
US8119393B2 (en) 2005-06-28 2012-02-21 Zbx Corporation Membrane array and analytical device
DE102005034174A1 (de) 2005-07-21 2007-02-08 B.R.A.H.M.S Ag Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen
CN1800384A (zh) * 2005-11-08 2006-07-12 浙江大学 降钙素原的制备方法
US20070224643A1 (en) 2006-03-09 2007-09-27 Mcpherson Paul H Methods and compositions for the diagnosis of diseases of the aorta
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
EP2020603A1 (de) 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Verfahren zur Einteilung von Risikoklassen bei stabiler Erkrankung der Koronaraterien
EP2174143B1 (de) * 2007-08-03 2011-06-22 B.R.A.H.M.S GmbH Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit
DE102008037108A1 (de) 2008-08-08 2010-02-11 Samson Aktiengesellschaft System zum Stellen eines Stellorgans
ES2601104T3 (es) * 2009-10-13 2017-02-14 B.R.A.H.M.S Gmbh Procalcitonina para el diagnóstico de infecciones bacterianas y la guía del tratamiento antibiótico en pacientes con apoplejía aguda o accidente isquémico transitorio
US20110263438A1 (en) 2010-04-22 2011-10-27 Mehmet Ali Soylemez Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin

Also Published As

Publication number Publication date
JP5059943B2 (ja) 2012-10-31
JP2012237760A (ja) 2012-12-06
EP2293076A2 (de) 2011-03-09
EP2174143A2 (de) 2010-04-14
US10456364B2 (en) 2019-10-29
EP2293078B1 (de) 2011-11-09
EP2301626B1 (de) 2013-01-16
ES2403310T3 (es) 2013-05-17
CN101790687A (zh) 2010-07-28
ATE514091T1 (de) 2011-07-15
US20190224135A1 (en) 2019-07-25
US11241395B2 (en) 2022-02-08
CN103123359A (zh) 2013-05-29
JP2010536012A (ja) 2010-11-25
HK1183707A1 (en) 2014-01-03
CN110346577A (zh) 2019-10-18
DE602008021800C5 (de) 2022-05-05
EP2293076B1 (de) 2012-12-19
WO2009019230A3 (en) 2009-04-23
WO2009019230A4 (en) 2009-06-25
ES2377112T3 (es) 2012-03-22
EP2293078A2 (de) 2011-03-09
EP2301626A3 (de) 2011-11-16
EP2301626A2 (de) 2011-03-30
EP2174143B1 (de) 2011-06-22
JP5185460B2 (ja) 2013-04-17
CN103123359B (zh) 2015-07-29
EP2293078A3 (de) 2011-04-06
EP2293076A3 (de) 2011-03-30
ES2401703T3 (es) 2013-04-23
WO2009019230A2 (en) 2009-02-12
US20110152170A1 (en) 2011-06-23
US20110136161A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
EP2293078A3 (de) Verfahren zur Diagnose bakterieller Infektionen
DE602006007703D1 (de) Verbesserte immuntestverfahren
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
BR112013006764A2 (pt) método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente
WO2010041046A8 (en) Granin proteins as markers of heart disease
WO2008040328A3 (de) Diagnose von infektionen oder entzündungserkrankungen der atemwege und lunge assoziiert mit herzinsuffizienz
WO2010041892A3 (ko) Aimp1 폴리펩티드의 신규한 용도
MX382244B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
EP2520935A3 (de) Organspezifische Proteine und Verfahren zu deren Verwendung
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
EP2052089A4 (de) Embryonale stammzellenmarker zur krebsdiagnose und -prognose
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
ATE518139T1 (de) Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
WO2008067806A3 (de) Diagnose und risikostratifizierung von herzinsuffizienz mittels neurophysin
FR2946349B1 (fr) Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine
WO2009014342A3 (en) Markers and kit for diagnosis of alzheimer's disease
EA201490576A1 (ru) Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
FR2930036B1 (fr) Procede de diagnostic d'une hypertension arterielle pulmonaire.
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal
GB0706558D0 (en) Diagnostic assay
ATE406579T1 (de) Verfahren zur diagnose von tumoren
BR112012023485A2 (pt) marcadores moleculares para infecções do trato urinário.